NEU 3.12% $16.76 neuren pharmaceuticals limited

It's pretty clear which company was the real target of the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,058 Posts.
    lightbulb Created with Sketch. 490
    It's pretty clear which company was the real target of the Report. The respective share price responses tell that story. Currently, Neuren with a vastly minor interest in Daybue, the relevant content of the Report, compared to Acadia's stake, sits at a hefty share price disadvantage. Makes no sense. Oh wait, Neuren is in discussions, Neuren has NNZ 2591, Neuren's shares are tightly held, oh...I get it.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.76
Change
-0.540(3.12%)
Mkt cap ! $2.126B
Open High Low Value Volume
$17.50 $17.55 $16.58 $6.706M 395.7K

Buyers (Bids)

No. Vol. Price($)
14 835 $16.76
 

Sellers (Offers)

Price($) Vol. No.
$16.78 698 8
View Market Depth
Last trade - 14.37pm 15/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.